PMID- 35596008 OWN - NLM STAT- MEDLINE DCOM- 20220913 LR - 20220921 IS - 1436-6215 (Electronic) IS - 1436-6207 (Linking) VI - 61 IP - 7 DP - 2022 Oct TI - The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial. PG - 3499-3516 LID - 10.1007/s00394-022-02898-9 [doi] AB - AIMS: To compare the effects of replacing regular dietary oils intake with sesame (SO), canola (CO), and sesame-canola (SCO) oils (a novel blend), on cardiometabolic markers in adults with type 2 diabetes mellitus (T2DM), in a triple-blind, three-way, randomized, crossover clinical trial. METHODS: Participants were assigned to receive SO, CO, and SCO in three 9-week phases (4 weeks apart). Cardiometabolic makers (serum lipids, Apolipoprotein, cardiovascular risk scores, kidney markers, and blood pressure) were considered at the beginning and the end of intervention phases. RESULTS: Ninety-two, ninety-five, and ninety-five participants completed the SO, SCO, and CO periods, respectively. After CO consumption, serum Apo A-1 concentrations were significantly higher compared with the SCO period in the whole population (p < 0.05). A considerable reduction in visceral adiposity index values was seen in the CO compared with the SO period in males (p < 0.05). Serum high-density lipoprotein concentration was also significantly higher after the SO intake compared with SCO in females (p < 0.05). The between-period analysis showed a substantial reduction in diastolic blood pressure in the SCO period compared with the CO and SO periods and lower systolic blood pressure after SCO versus CO intake in males (p < 0.05). CONCLUSIONS: Canola oil might protect CVD through improving Apo A-1 levels in patients with T2DM (particularly in females) and visceral adiposity index in male patients. However, the blend oil might beneficially affect blood pressure in men. Future sex-specific studies might warrant the current findings. REGISTRY OF CLINICAL TRIALS: This trial was registered in the Iranian Registry of Clinical Trials (IRCT, registration ID: IRCT2016091312571N6). CI - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. FAU - Amiri, Mojgan AU - Amiri M AD - Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AD - Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. FAU - Raeisi-Dehkordi, Hamidreza AU - Raeisi-Dehkordi H AD - Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AD - Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. FAU - Moghtaderi, Fatemeh AU - Moghtaderi F AD - Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AD - Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. FAU - Zimorovat, Alireza AU - Zimorovat A AD - Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AD - Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. FAU - Mohyadini, Matin AU - Mohyadini M AD - Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AD - Department of Medical Laboratory Sciences, School of Para Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. FAU - Salehi-Abargouei, Amin AU - Salehi-Abargouei A AUID- ORCID: 0000-0002-7580-6717 AD - Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. abargouei@ssu.ac.ir. AD - Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. abargouei@ssu.ac.ir. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20220521 PL - Germany TA - Eur J Nutr JT - European journal of nutrition JID - 100888704 RN - 0 (Apolipoprotein A-I) RN - 0 (Biomarkers) RN - 0 (Plant Oils) RN - 0 (Rapeseed Oil) RN - 8008-74-0 (Sesame Oil) SB - IM MH - Adult MH - Apolipoprotein A-I MH - Biomarkers MH - *Cardiovascular Diseases/prevention & control MH - Cross-Over Studies MH - *Diabetes Mellitus, Type 2/complications MH - Female MH - Humans MH - Iran MH - Male MH - Obesity, Abdominal MH - *Plant Oils/pharmacology MH - Rapeseed Oil MH - Sesame Oil OTO - NOTNLM OT - Apolipoprotein OT - Canola oil OT - Cardiovascular risk factors OT - Dietary oils OT - Dyslipidemia OT - Hypertension OT - Lipids OT - Lipoproteins OT - Rapeseed oil OT - Sesame oil OT - Type 2 diabetes mellitus EDAT- 2022/05/21 06:00 MHDA- 2022/09/14 06:00 CRDT- 2022/05/20 23:29 PHST- 2021/04/07 00:00 [received] PHST- 2022/04/22 00:00 [accepted] PHST- 2022/05/21 06:00 [pubmed] PHST- 2022/09/14 06:00 [medline] PHST- 2022/05/20 23:29 [entrez] AID - 10.1007/s00394-022-02898-9 [pii] AID - 10.1007/s00394-022-02898-9 [doi] PST - ppublish SO - Eur J Nutr. 2022 Oct;61(7):3499-3516. doi: 10.1007/s00394-022-02898-9. Epub 2022 May 21.